Sodium thiosulfate for calciphylaxis treatment in patients on peritoneal dialysis: a systematic review

C Gossett, S Suppadungsuk, P Krisanapan… - Medicina, 2023 - mdpi.com
Limited data are available on the utilization of sodium thiosulfate (STS) treatment for
calciphylaxis in peritoneal dialysis (PD) patients, while it is well-studied in hemodialysis …

Sailing between scylla and charybdis—anticoagulation dilemma in a patient with calciphylaxis and mechanical cardiac valve replacement: a case report and literature …

S Liang, M Guan, Z Liu, X Ruan, H Huang… - Renal Failure, 2023 - Taylor & Francis
Calciphylaxis is a rare and life-threatening condition in patients with end-stage kidney
disease (ESKD). In this case report, we reported a 72-year-old female who had undergone …

Warfarin-induced calciphylaxis-related skin ulceration in patients with end-stage renal disease: case report and literature review

V Vallini, R Andreini, G Sibilia, L Venturini… - Journal of Wound …, 2024 - magonlinelibrary.com
Calciphylaxis is a rare but highly disabling disease, occurring both in chronic kidney disease
(CKD) with renal replacement therapy (RRT) and in normal renal function. Given the …

[HTML][HTML] Calciphylaxis: A Rare Complication With a Fatal Outcome in End-Stage Renal Disease

AD Khudair, AD Khudair, M Awadh, NSP Romano… - Cureus, 2023 - ncbi.nlm.nih.gov
Calciphylaxis, or calcific uremic arteriolopathy, is a rare and deadly disease that affects
patients with end-stage renal disease (ESRD). It typically manifests in the abdomen and …

[PDF][PDF] Calciphylaxis: A Rare Clinical Presentation in a Patient with End-Stage Renal Disease (ESRD)

A Okikiade, T Browne-Caesar, O Afolayan-Oloye… - Skin - researchgate.net
Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), affects small arteries of
the skin in patients with end-stage renal failure, dialysis patients, and patients with …